New White Paper: Utilization of technologies and process analytical tools to overcome lyophilization challenges during development, scale-up and manufacturing of biologic products
This White Paper describes the challenges associated with lyophilization of biologic drug products. Using a Quality by Design (QbD) approach with SP Scientiﬁc’s Line of Sight™ (LOS) suite of technologies that provide a data-rich environment, many of these challenges can be overcome. In particular, scaling-up of lyophilization from early development to full commercialization can be streamlined through the use of scalable technologies available within the Line of Sight™ portfolio.
For more information, visit our Line of Sight microsite